Royalty Pharma plcRoyalty Pharma plcRoyalty Pharma plc

Royalty Pharma plc

No trades
See on Supercharts

RPRX fundamentals

Royalty Pharma plc key financial stats and ratios

RPRX price-to-sales ratio is 5.25. The company has an Enterprise Value to EBITDA ratio of 17.40. As of 2023 they employed 89.00 people.

Statistics
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
‪0.00‬
Price to earnings ratio
Price to cash flow ratio
Currency: USD
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Current
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios